NCT05867940 Effects of Physical Activity on Prescription (PAP) as a Health-enhancing Intervention in People With Disabilities
| NCT ID | NCT05867940 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Region Skane |
| Condition | Physical Inactivity |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2023-06-05 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2023-06-05 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Physical inactivity is an increasing problem in the general population in society. However, in people with disabilities, inactivity is even more frequently reported. Physical activity on prescription (PAP) is a well-established method to enhance physical activity. The prescribed physical activity can be activities such as walking, cycling, swimming, or gardening, and should be performed over a longer period. In children with cerebral palsy, PAP has shown to be feasible to increase participation in physical activity and to reduce sedentary behaviour, and the habilitation services in the Region of Skåne have decided to offer PAP to all children and youth with disabilities. It is of great importance to study these interventions when applied on a broader group of patients than previously studied. The aim is to study the effects of an individualised and health-enhancing intervention in physically inactive people with autism, intellectual and physical disabilities. Also, the cost-effectiveness of PAP will be studied. 60 physically inactive children, aged 8- 17 years, and 20 adults, with autism, intellectual or physical disability will be included. The participants are recruited by their clinical physiotherapists, who also will be carrying out the PAP-intervention. The self-selected physical activity/activities may either be a physical activity organized by a club and/or an everyday activity such as walking a dog or riding a bicycle to school. Each participant fills in an activity logbook. Motivational interviewing will be used to support the participants. The Canadian Occupational Performance Measure can be used to identify what activities the participants are motivated to do, and to detect changes in the participants' perception of their performance of the activity. Quality of life will be monitored. Physical activity will be measured through the International Physical Activity Questionnaire (IPAQ) and a movement monitor (accelerometer). Study specific questionnaires will be filled in regarding costs and background information. Data on health care use of the participants will retrospectively be collected and studied using the health care database in Region Skåne. Data will be collected at 3 months prior to the intervention, just before the intervention starts, when the intervention is finished, and at 6, 12 and 24 months after the intervention. The study has been approved by the Swedish Ethical Review Authority.
Eligibility Criteria
Inclusion Criteria: * Physical inactivity * Not meeting the physical activity recommendations * Much sedentary time * Physical disability * Intellectual disability * Autism * Living in the Skåne Region in Sweden * Receiving treatment from the habilitation Services in the Skåne Region, Sweden Exclusion Criteria: * Meeting the physical activity recommendations
Contact & Investigator
Katarina Lauruschkus, PhD
PRINCIPAL INVESTIGATOR
Region Skåne Sweden
Frequently Asked Questions
Who can join the NCT05867940 clinical trial?
This trial is open to participants of all sexes, aged 8 Years or older, studying Physical Inactivity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05867940 currently recruiting?
Yes, NCT05867940 is actively recruiting participants. Contact the research team at katarina.lauruschkus@med.lu.se for enrollment information.
Where is the NCT05867940 trial being conducted?
This trial is being conducted at Malmö, Sweden.
Who is sponsoring the NCT05867940 clinical trial?
NCT05867940 is sponsored by Region Skane. The principal investigator is Katarina Lauruschkus, PhD at Region Skåne Sweden. The trial plans to enroll 80 participants.